Breaking News
Thursday , August 24 2017
Home / Business / Cadila Healthcare’s Topical manufacturing facility successfully completes USFDA inspection

Cadila Healthcare’s Topical manufacturing facility successfully completes USFDA inspection

Cadila Healthcare’s Topical manufacturing located at Changodar was successfully inspected by US Food & Drug Administration (USFDA) from April 3 to April 7, 2017. At the end of the inspection, no observation (483) is issued. The company has filed 17 products with the USFDA from this manufacturing facility.

Cadila Healthcare is part of the Zydus Cadila Group. The company operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals. Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.

Loading...

About editor

Close